DE69713367T2 - Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit veränderter wirkstoffsfreisetzung, enthaltend eine matrix - Google Patents
Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit veränderter wirkstoffsfreisetzung, enthaltend eine matrixInfo
- Publication number
- DE69713367T2 DE69713367T2 DE69713367T DE69713367T DE69713367T2 DE 69713367 T2 DE69713367 T2 DE 69713367T2 DE 69713367 T DE69713367 T DE 69713367T DE 69713367 T DE69713367 T DE 69713367T DE 69713367 T2 DE69713367 T2 DE 69713367T2
- Authority
- DE
- Germany
- Prior art keywords
- matrix
- producing
- pharmaceutical composition
- active substance
- modified active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9612156A FR2753904B1 (fr) | 1996-10-01 | 1996-10-01 | Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication |
PCT/FR1997/001710 WO1998014176A1 (fr) | 1996-10-01 | 1997-09-29 | Procede de fabrication d'une composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69713367D1 DE69713367D1 (de) | 2002-07-18 |
DE69713367T2 true DE69713367T2 (de) | 2003-03-06 |
Family
ID=9496393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69713367T Expired - Lifetime DE69713367T2 (de) | 1996-10-01 | 1997-09-29 | Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit veränderter wirkstoffsfreisetzung, enthaltend eine matrix |
Country Status (9)
Country | Link |
---|---|
US (1) | US6194005B1 (de) |
EP (1) | EP0935459B1 (de) |
JP (1) | JP2001501218A (de) |
KR (1) | KR20000048761A (de) |
AU (1) | AU4464897A (de) |
DE (1) | DE69713367T2 (de) |
ES (1) | ES2176785T3 (de) |
FR (1) | FR2753904B1 (de) |
WO (1) | WO1998014176A1 (de) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2779651B1 (fr) * | 1998-06-16 | 2001-04-20 | Gattefosse Ets Sa | Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero |
FR2784895B1 (fr) * | 1998-10-23 | 2004-12-17 | Gattefosse Ets Sa | Comprime a croquer a gout masque et liberation immediate du principe actif et procede de fabrication |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
EP1623703B1 (de) | 1999-10-29 | 2011-10-05 | Euro-Celtique S.A. | Hydrocodon-Formulierungen mit gesteuerter Freisetzung |
SK285128B6 (sk) * | 1999-12-28 | 2006-07-07 | Zentiva, A. S. | Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy |
HU230686B1 (en) | 2000-10-30 | 2017-08-28 | Euro Celtique Sa | Controlled release hydrocodone compositions |
FR2822381B1 (fr) * | 2001-03-20 | 2004-10-22 | Bio Obtention Sc | Extrait de cucumis melo enrobe et/ou microencapsule dans un agent liposoluble a base de matiere grasse |
SK286107B6 (sk) * | 2002-04-12 | 2008-03-05 | Zentiva, A. S. | Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy |
US20040043070A1 (en) * | 2002-05-14 | 2004-03-04 | Ayres James W. | Hot melt coating by direct blending and coated substrates |
US20030235613A1 (en) * | 2002-06-19 | 2003-12-25 | Cts Chemical Industries Ltd. | Popping oral administration form |
US20070141071A1 (en) * | 2003-05-14 | 2007-06-21 | Oregon State University | Hot melt coating by direct blending and coated substrates |
US7364755B2 (en) * | 2003-07-07 | 2008-04-29 | Synthon Ip Inc. | Modified calcium phosphate excipient |
US20080069891A1 (en) | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
EP1972336A1 (de) * | 2007-03-19 | 2008-09-24 | LEK Pharmaceuticals D.D. | Heißschmelz-Mikropellets |
DE102007026550A1 (de) | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
US20090004285A1 (en) * | 2007-06-29 | 2009-01-01 | Liangping Yu | Stable non-disintegrating dosage forms and method of making same |
FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
WO2011143120A1 (en) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcoholres i stant metoprolol - containing extended - release oral dosage forms |
US11071805B2 (en) | 2013-04-22 | 2021-07-27 | Sealantium Medical Ltd. | Fibrinogen-based tissue adhesive patches |
US11471556B2 (en) | 2015-10-19 | 2022-10-18 | Sealantium Medical Ltd. | Fibrinogen-based tissue adhesive patch |
CA3008674C (en) | 2015-10-19 | 2024-02-13 | Sealantium Medical Ltd | Improved fibrinogen-based tissue adhesive patch |
US20180207328A1 (en) * | 2017-01-22 | 2018-07-26 | Kamalesh K. Rao | Implantable Compositions for Pain Management |
CA3087126A1 (en) * | 2017-12-27 | 2019-07-04 | Graal S.R.L. | Process for the preparation of delayed release solid formulations |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4129666A (en) | 1977-04-29 | 1978-12-12 | Walter Wizerkaniuk | Method of providing pellets with a water insoluble coating using a melt |
FR2573307B1 (fr) * | 1984-11-22 | 1988-06-10 | Virbac Ctre Rech Biolog | Implants anabolisants a liberation prolongee |
EP0421581A1 (de) | 1989-10-03 | 1991-04-10 | Warner-Lambert Company | Kaubare sprühgetrocknete spheroide Mikrokapseln, wachsüberzogene Mikrokapseln und Verfahren zu ihrer Herstellung |
DE4001622A1 (de) * | 1990-01-20 | 1991-07-25 | Thomae Gmbh Dr K | Orale arzneimittelformen von pimobendan |
JPH03232814A (ja) * | 1990-02-08 | 1991-10-16 | Shin Etsu Chem Co Ltd | 徐放性錠剤の製造方法 |
JP3078859B2 (ja) * | 1990-02-23 | 2000-08-21 | 武田薬品工業株式会社 | 安定な放出制御性製剤用コーティング剤 |
JP2553258B2 (ja) | 1991-05-20 | 1996-11-13 | 三菱化学株式会社 | ワックス被覆製剤の製造方法 |
GB9224855D0 (en) * | 1992-11-27 | 1993-01-13 | Smithkline Beecham Plc | Pharmaceutical compositions |
SE9301112D0 (sv) * | 1993-04-02 | 1993-04-02 | Orion-Yhtymae Oy | A new composition |
IL109770A0 (en) | 1993-05-29 | 1994-11-28 | Smithkline Beecham Corp | Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby |
DK0744941T3 (da) * | 1994-02-16 | 2003-09-29 | Abbott Lab | Fremgangsmåde til fremstilling af findelte farmaceutiske formuleringer |
-
1996
- 1996-10-01 FR FR9612156A patent/FR2753904B1/fr not_active Expired - Lifetime
-
1997
- 1997-09-29 KR KR1019990702747A patent/KR20000048761A/ko active IP Right Grant
- 1997-09-29 ES ES97943017T patent/ES2176785T3/es not_active Expired - Lifetime
- 1997-09-29 EP EP97943017A patent/EP0935459B1/de not_active Expired - Lifetime
- 1997-09-29 AU AU44648/97A patent/AU4464897A/en not_active Abandoned
- 1997-09-29 JP JP10516277A patent/JP2001501218A/ja not_active Ceased
- 1997-09-29 US US09/269,468 patent/US6194005B1/en not_active Expired - Lifetime
- 1997-09-29 DE DE69713367T patent/DE69713367T2/de not_active Expired - Lifetime
- 1997-09-29 WO PCT/FR1997/001710 patent/WO1998014176A1/fr active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
FR2753904A1 (fr) | 1998-04-03 |
FR2753904B1 (fr) | 1998-10-30 |
WO1998014176A1 (fr) | 1998-04-09 |
EP0935459A1 (de) | 1999-08-18 |
AU4464897A (en) | 1998-04-24 |
ES2176785T3 (es) | 2002-12-01 |
EP0935459B1 (de) | 2002-06-12 |
KR20000048761A (ko) | 2000-07-25 |
US6194005B1 (en) | 2001-02-27 |
DE69713367D1 (de) | 2002-07-18 |
JP2001501218A (ja) | 2001-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69713367T2 (de) | Verfahren zur herstellung einer pharmazeutischen zusammensetzung mit veränderter wirkstoffsfreisetzung, enthaltend eine matrix | |
DE790240T1 (de) | Phenol-Derivate mit pharmazeutischer Aktivität und Verfahren zu ihrer Herstellung | |
ATA125988A (de) | Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung | |
DE58904479D1 (de) | Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung. | |
DE69811735D1 (de) | Heterocyclische verbindungen zur hemmung der magensäureproduktion, verfahren zu ihrer herstellung und pharmazeutische zubereitungen davon | |
ATE234291T1 (de) | Metallproteinasehemmer, diesen enthaltende pharmazeutische zusammensetzung und dessen pharmazeutische verwendung und verfahren zu ihrer herstellung | |
ATE307576T1 (de) | Fenofibrathaltige arzneizusammensetzung mit erhöhter bioverfügbarkeit und verfahren zu deren herstellung | |
DE60043701D1 (de) | Verfahren zur herstellung von calendulasäure, einer fettsäure mit delta-8,10,12 konjugierten doppelbindungen und dimorphekolinsäure, einer fettsäure mit einer 9-hydroxyl-gruppe und delta-10,12 konjugierten doppelbindungen | |
DE3780226D1 (de) | Neue pharmazeutische praeparate zur topischen applikation, verfahren zu ihrer herstellung und ihre verwendung. | |
DE69010919D1 (de) | Dentale abdrucklöffel sowie verfahren zur herstellung. | |
DE69411604D1 (de) | Wirkstoffzusammensetzung und Verfahren zu ihrer Herstellung | |
DE68924533T2 (de) | Knochenwachstumsmatrix und verfahren zu ihrer herstellung. | |
DE69005987T2 (de) | Dichtung, Vorrichtung und Verfahren zur ihrer Herstellung. | |
DE59608606D1 (de) | Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung | |
DE69800805D1 (de) | Verfahren zur herstellung chiraler 3,4-epoxybuttersäure und ihrer salze | |
ATE143010T1 (de) | Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen | |
DE68905625D1 (de) | Verfahren zur herstellung aromatischer hydroxycarbonsaeuren. | |
DE3888036D1 (de) | Optisch aktive Verbindung, Verfahren zur ihrer Herstellung und sie enthaltende flüssigkristalline Zusammensetzung. | |
DE69012650T2 (de) | Piperidinderivat, Verfahren zur Herstellung davon und dieses enthaltende pharmazeutische Zusammensetzung. | |
DE69828191D1 (de) | Verfahren zur herstellung von 2,6-dialkylnaphthalin | |
DE59310184D1 (de) | Verfahren zur herstellung dünnflüssiger, lagerstabiler amphotenside | |
DE69026906D1 (de) | Arylpyrrol enthaltende insekticidale, acaricidale und nematicidale Mittel sowie Verfahren zu ihrer Herstellung | |
DE69715667T2 (de) | Verfahren zur herstellung einer multipartikulären pharmazeutischen form mitgesteuerter etappenweiser freisetzung | |
DE68905837D1 (de) | 2-(alkyl-cyclohexyl)-1-propanol, verfahren zu dessen herstellung und ihn enthaltende riechstoffzusammensetzung. | |
ATE136299T1 (de) | Verfahren zur herstellung der racemischen und optisch aktiven 1,2,3,4-tetrahydroisochinolin-3- carbonsäure sowie deren vorprodukte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: GATTEFOSSE HOLDING, SAINT PRIEST, FR |
|
8364 | No opposition during term of opposition |